Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia

Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemiaInfluence of <i>BCL2L11</i> polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia, Published online: 27 December 2017; doi:10.1038/s41397-017-0002-4Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia

Source: The Pharmacogenomics Journal - December 27, 2017 Category: Drugs & Pharmacology Authors: Maria Plesa Vincent Gagn é Sanja Glisovic Melissa Younan Bahram Sharif-Askari Caroline Laverdi ère Nathalie Alos Jean-Marie Leclerc Stephen E Sallan Donna Neuberg Jeffery L Kutok Lewis B Silverman Daniel Sinnett Maja Krajinovic Source Type: research